Tech Company Financing Transactions

Providence Medical Technology Funding Round

On 9/21/2018, Providence Medical Technology received $25 million in funding from Revelation Partners, Aphelion Capital and BMO Asset Management.

Transaction Overview

Company Name
Providence Medical Technology
Announced On
9/21/2018
Transaction Type
Venture Equity
Amount
$25,000,000
Round
Undisclosed
Investors

Revelation Partners (Lead Investor) (Zack Scott)

Aphelion Capital (Ned Scheetz)

BMO Asset Management

MedVest Capital

MVM Life Science Partners (Bali Muralidhar)

Proceeds Purpose
The proceeds of the financing will be used to accelerate commercial expansion and clinical development of its DTRAX line of cervical fusion instruments designed to help patients suffering from advanced cervical spine conditions.

Company Information

Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
3875 Hopyard Rd. 300
Pleasanton, CA 94588
USA
Phone
(415) 923-9376
Website
www.providencemt.com
Email Address
[email protected]
Overview
A privately-held medical device company developing minimally invasive solutions addressing the $1 billion worldwide cervical spine market. Commercializing the DTRAX platform of minimally invasive posterior cervical implants and instruments to treat cervical degenerative disc disease through indirect decompression and stabilization.
Profile
Providence Medical Technology LinkedIn Company Profile
Social Media
Providence Medical Technology Company Twitter Account
Company News
Providence Medical Technology News
Facebook
Providence Medical Technology on Facebook
YouTube
Providence Medical Technology on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Jeffrey Smith
  Jeffrey Smith LinkedIn Profile  Jeffrey Smith Twitter Account  Jeffrey Smith News  Jeffrey Smith on Facebook
Chief Operating Officer
Edward Liou
  Edward Liou LinkedIn Profile  Edward Liou Twitter Account  Edward Liou News  Edward Liou on Facebook
Vice President
Michael Scott
  Michael Scott LinkedIn Profile  Michael Scott Twitter Account  Michael Scott News  Michael Scott on Facebook
VP - Marketing
Scott Lynch
  Scott Lynch LinkedIn Profile  Scott Lynch Twitter Account  Scott Lynch News  Scott Lynch on Facebook
VP - R & D
Shigeru Tanaka
  Shigeru Tanaka LinkedIn Profile  Shigeru Tanaka Twitter Account  Shigeru Tanaka News  Shigeru Tanaka on Facebook
VP - Regulatory Affairs
Janie Mandrusov
  Janie Mandrusov LinkedIn Profile  Janie Mandrusov Twitter Account  Janie Mandrusov News  Janie Mandrusov on Facebook
VP - Sales
Jeremy Laynor
  Jeremy Laynor LinkedIn Profile  Jeremy Laynor Twitter Account  Jeremy Laynor News  Jeremy Laynor on Facebook

 

 

Browse more venture capital transactions:

Prev: 9/21/2018: Galera Therapeutics venture capital transaction
Next: 9/24/2018: ATTN venture capital transaction

 

Share this article

 

Where The Data Comes From

We record all VC transactions involving tech companies. VC investment data records reported here come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary

 

Copyright © 2001-2024. Gaebler Ventures. All rights reserved.